Tolerance Induction During Therapy with Long-Acting Nitrates: How Extensive is the “Collateral Damage”?

ISSN： 0920-3206

Source： Cardiovascular Drugs and Therapy, Vol.18, Iss.1, 2004-01, pp. : 11-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Term Use of Short- and Long-Acting Nitrates in Stable Angina Pectoris

Current Clinical Pharmacology, Vol. 4, Iss. 2, 2009-05 ,pp. : 132-141

Bentham Science Publishers

Access to resources Recommend Favorite

Choice of Long-Acting Insulin Therapy for Type 2 Diabetes: How Can Treatment for Older People be Optimized?

By Krentz Andrew J. Sinclair Alan J.

Drugs & Aging, Vol. 28, Iss. 12, 2011-12 ,pp. : 935-941

Adis International

Access to resources Recommend Favorite

Long-Acting Isosorbide Mononitrate

By Prakash A. Markham A.

Drugs, Vol. 57, Iss. 1, 1999-01 ,pp. : 93-99

Adis International

Access to resources Recommend Favorite

Long-Acting Antipsychotic Medications

Current Drug Targets, Vol. 13, Iss. 4, 2012-04 ,pp. : 555-560

Bentham Science Publishers

Access to resources Recommend Favorite

Long-Standing Statin Therapy and the Risk of New-Onset Diabetes in the Elderly: Collateral Damage Caused by Preventive Medicine?

By Mascitelli Luca

Drugs & Aging, Vol. 29, Iss. 1, 2012-01 ,pp. : 9-13

Adis International

Access to resources Recommend Favorite